Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00237432 · ClinicalTrials.gov registry record

Study of the Immune Response to Hepatitis C Virus

A clinical trial of Hepatitis C, sponsored by Rockefeller University.

Completed
Registry status
11
Enrollment target
1
Study location

NCT00237432 is a study of Hepatitis C that has completed, run by Rockefeller University. The registered enrollment target is 11 participants, below the 1,890-participant average among 106 other Hepatitis C trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00237432, a study of Hepatitis C, has completed, sponsored by Rockefeller University.

COMPLETED
Registry status
11 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to investigate the mechanism of a successful immune response to hepatitis C virus (HCV) infection. Currently, it is believed that the immune system is involved in responding to HCV infection, but how it is involved is not known. It is estimated that 30% of individuals infected with HCV are able to clear the virus without treatment, while 70% progress to chronic infectious. By studying the immune responses in these two populations, we, the researchers at Rockefeller University, hope to gain insight into the mechanisms of the immune response and develop new strategies for HCV therapy.

Conditions Studied

Hepatitis C

Study Locations (1)

New York

  • Rockefeller University Hospital - New York

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2003-04
Est. Completion 2008-02

Sponsor

Rockefeller University

117 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00237432

The ClinicalTrials.gov registry entry for NCT00237432 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,890-participant average among 106 other Hepatitis C trials with a reported enrollment target (99% lower). The listed sponsor is Rockefeller University, which has 117 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hepatitis C appearing as the primary indexed condition, and to 0 interventions.

NCT00237432 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT00237432 about?

NCT00237432 is a clinical study titled "Study of the Immune Response to Hepatitis C Virus". The purpose of this study is to investigate the mechanism of a successful immune response to hepatitis C virus (HCV) infection. Currently, it is believed that the immune system is involved in responding to HCV infection, but how it is involved is not known. It is estimated that 30% of individuals in...

What is the current status of trial NCT00237432?

This trial is currently completed. The enrollment target is 11 participants. The study started on 2003-04. Estimated completion is 2008-02.

What conditions does trial NCT00237432 study?

This clinical trial studies the following conditions: Hepatitis C.

Who is sponsoring clinical trial NCT00237432?

This trial is sponsored by Rockefeller University, which has 117 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00237432 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Hepatitis C

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Hepatitis C

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.